NCT07134387 Long-Term Burden of BPD and Health-Related Quality of Life (BronQ Family)
| NCT ID | NCT07134387 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Global Foundation for the Care of Newborn Infants |
| Condition | Bronchopulmonary Dysplasia (BPD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 480 participants |
| Start Date | 2025-09-16 |
| Primary Completion | 2026-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 480 participants in total. It began in 2025-09-16 with a primary completion date of 2026-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to examine the long-term impact of having a child with Bronchopulmonary Dysplasia (BPD) on the parents and caregivers from the time of diagnosis through adulthood. The primary focus will be on parents and caregivers of children until the age of 18 (\< 18) years who were diagnosed with BPD as newborns. Data will be collected through an online questionnaire in France, Germany, Italy, the Netherlands, Spain, the United Kingdom (including Northern Ireland), and the United States. It will ask about inclusion and exclusion criteria, background information (caregiver, child, and family situation), the child's medical situation, parental health-related quality of life (HRQoL), health literacy, feelings, support structures, and economic burden of the family.
Eligibility Criteria
Inclusion Criteria: BPD-group: * Being a parent or primary caregiver of a child until the age of 18 years (0 to under 18 years), * who was born preterm (before 37 weeks of gestation), * who has been discharged from their initial hospital stay after birth, * who suffered from BPD in the newborn period and * who was born or is currently living in the following countries: France, Germany, Italy, the Netherlands, Spain, the United Kingdom (including Northern Ireland) and the United States * providing sufficient proficiency in one of the languages of the questionnaire Control group: * Being a parent or primary caregiver of a child until the age of 18 years (0 to under 18 years), * who was born preterm (before 37 weeks of gestation), * who has been discharged from their initial hospital stay after birth, * who did not suffer from BPD in the newborn period and * who was born or is currently living in the following countries: France, Germany, Italy, the Netherlands, Spain, the United Kingdom (including Northern Ireland) and the United States * providing sufficient proficiency in one of the languages of the questionnaire Exclusion Criteria: BPD-group: * Other family members than parents/primary caregivers * Parents or primary caregivers * of a child older/equal than 18 years of age * of a child with BPD who has not been discharged yet * of a child without a BPD in the newborn period * with insufficient proficiency in one of the languages available in the questionnaire Control group: * Other family members than parents/primary caregivers * Parents or primary caregivers * of children older/equal than 18 years of age * of a child born term * of a child without BPD who has not been discharged yet * with insufficient proficiency in one of the languages available in the questionnaire
Contact & Investigator
Julia Feiler, Dr
PRINCIPAL INVESTIGATOR
Global Foundation for the Care of Newborn Infants (GFCNI)
Frequently Asked Questions
Who can join the NCT07134387 clinical trial?
This trial is open to participants of all sexes, aged 0 Years or older, up to 18 Years, studying Bronchopulmonary Dysplasia (BPD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07134387 currently recruiting?
Yes, NCT07134387 is actively recruiting participants. Contact the research team at research@efcni.org for enrollment information.
Where is the NCT07134387 trial being conducted?
This trial is being conducted at München, Germany.
Who is sponsoring the NCT07134387 clinical trial?
NCT07134387 is sponsored by Global Foundation for the Care of Newborn Infants. The principal investigator is Julia Feiler, Dr at Global Foundation for the Care of Newborn Infants (GFCNI). The trial plans to enroll 480 participants.